Harshith Thyagaturu

Assistant Professor Non-Invasive Cardiology @WVUMedicine | Researching SDOH & medical expenditures | Focused on patient outcomes & health equity.

[EJPC Editor-in-Chief @EJPCEiC]

This systematic review and meta-analysis suggests that LDL-C-lowering therapies may offer a greater benefit in preventing first-time MI compared with recurrent MI
📖 https://t.co/kInqtRgfMc
@escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic

[CardioTeca @cardioteca]

Cinco años después, la Sociedad Europea de Cardiología reescribe la insuficiencia cardíaca de arriba abajo. Y esta vez no son retoques.
🔴 Desaparece la insuficiencia cardíaca con FEVI ligeramente reducida.
🫀 La FEVI reducida pasa a abarcar todo lo que esté por debajo del 50%.
📈 Los estadios A, B, C y D entran por fin en la guía europea.
💊 Nace el tratamiento médico fundamental, con cuatro fármacos en la FEVI reducida y dos en la preservada.
🧪 Estreno de un sistema de niveles de evidencia con cuatro escalones: A, B1, B2 y C.
🩸 La ferropenia se redefine por la saturación de transferrina.
🏥 La insuficiencia cardíaca aguda pasa a llamarse descompensada, con tres fases de tratamiento hospitalario.
⚖️ Y una asimetría que dará que hablar: para el mismo paciente con FEVI ≥40%, esta guía recomienda el antagonista mineralocorticoideo con clase I y la guía renal hermana, publicada el mismo día, con clase IIa.
📖 Te lo hemos resumido todo, cambio por cambio y con las clases de recomendación al lado.

https://t.co/rH3HJmm2ab

[WVU Department of Medicine @wvudeptofmed]

Medicine Grand Rounds Photos!

Thank you to everyone who joined us in the Fukushima Auditorium today for our awesome presentation, “Evaluating Myocardial Ischemia: Navigating the Roles of SPECT and PET MPI”.

Special thanks to our speaker:
🔬 Harshith Thyagaturu, MD, MS, FACC

[Alison L. Bailey, MD @a_l_bailey]

@WvuCvFellows

[Sourbha Satish Dani, MD, MSc, FACC, FASE @SaurabhSDani]

Cost-effectiveness analysis is one of the most elegant frameworks in health economics — and one of the most debated. Let me walk you through its history in US healthcare, how it applies to cardiology, and why every clinician should understand it. A thread. 🧵

[Harsh A Patel @Harshp2802]

🚨 Thrilled to share Our 📝 assesing how well traditional CV risk scores🫀 (PCE, Framingham, PREVENT) predict mortality for cancer survivors, out now in @CurrentOncology! 👇

@DrBrijPatel @harshi_md
🧵1/3

[Amro Taha @Amrotahaa]

Excited to share our latest publication in @JAHA_AHA on DOAC vs VKA for stroke prevention in hypertrophic cardiomyopathy with atrial fibrillation.

In this real-world analysis, DOACs were associated with improved safety while maintaining effectiveness.

🔗 https://t.co/E01IDtLJOM

[Prakash Upreti MD @DrLubDubMD]

Publication alert🚑: Environmental heavy metals & CV mortality — new insights 🫀🌍

Database: NHANES 1999–2018 (n=55,081)

🔴 Higher Lead & Cadmium → ↑ CVD mortality
🟢 Higher Mercury → ↓ CVD mortality (complex relationship)

Conclusion: Environmental factors affect your CV health.

🔗 https://t.co/BqC5O0QC35

@KarthikG_MD @harshi_md @HValandMD @Eng_WaqarYounas @AlruwailiWS @dipesh_ludhwani @Ayeshaashaik @DryasarsattarMD @DrMarthaGulati @AJPCardio

#CardioTwitter #PreventionCardiology #EnvironmentalHealth #NHANES #PublicHealth #Cardiology #MedTwitter #EpiTwitter #CVD #Research

[John Mandrola, MD @drjohnm]

My choices for the worst interventional trials that changed practice nonetheless were…

FAME 2
TRILUMINATE
EARLY TAVR

[Harshith Thyagaturu @harshi_md]

@MobeenMZH @WvuCvFellows @CvWvu @sudarshanballa @Lakshmi14524052 @LaeeqRida @havistin @BritoCardio @DrBrijPatel @RayRcnita @Heart_SCCT @baselabdelazeem @DrAamirLaghari Congratulations, Mobeen!

[Harshith Thyagaturu @harshi_md]

@sudarshanballa @WvuCvFellows @CASivaram1 @argulian @cardiooncCMB Pleural effusion, small per effusion and is that a dilated coronary sinus Or dilated descending aortic aneurysm? Doesn't look pulsatile- would go with dilated cor sinus.

[Harshith Thyagaturu @harshi_md]

Welcome to WVU! Looking forward to working with you all.

[Sudarshan Balla @sudarshanballa]

Excited about our cardiology match at WVU. Welcome to WVU - we have great expectations and I am sure you will rise to the task @WvuCvFellows #ACCFIT @docsok99 @RameshDaggubati @cardiooncCMB @harshi_md

[Harshith Thyagaturu @harshi_md]

@sthangjui @WvuCvFellows @sudarshanballa @jkewcharoen Congratulations, Oh!!

[Harshith Thyagaturu @harshi_md]

@HWatson2024 Congratulations, Helen!!

[JAHA @JAHA_AHA]

New study finds #COVID19 vaccination linked to lower mortality in high-risk CAD/HF patients, supporting its use in secondary prevention. #CardioTwitter @usman_aliakbar @sudarshanballa https://t.co/qDGEuY6YZZ

[Harsh A Patel @Harshp2802]

From research daydreams to reality: my first #AHA2025, unforgettable experience!

Honored to present my work at AHA (6 abstracts). Deep gratitude to my mentors @DrBrijPatel @harshi_md @sthangjui @HWatson2024 this would not have been possible without their guidance and support.

[V.L.Sorrell, MD (@CASEfromASE EIC) @VLSorrellImages]

#JADEL

Complication after electrical cardioversion:
https://t.co/ogOW6fJree

A. Takotsubo-induced septal rupture
B. Unmasked congenital heart disease
C. Unrelated cardiomyopathy
D. Aortic dissection with severe AR

@ASE360

[Harshith Thyagaturu @harshi_md]

https://t.co/hHLQLnqx3G

[V.L.Sorrell, MD (@CASEfromASE EIC) @VLSorrellImages]

#JADEL

Complication after electrical cardioversion:
https://t.co/ogOW6fJree

A. Takotsubo-induced septal rupture
B. Unmasked congenital heart disease
C. Unrelated cardiomyopathy
D. Aortic dissection with severe AR

@ASE360

[Sudarshan Balla @sudarshanballa]

A very rare complication - Takotsubo Cardiomyopathy Triggered by Electrical Cardioversion and Com... https://t.co/QojEiHsQxZ
Congrats to the team of resident /fellow at WVU @Amrotahaa @DanielBritoGuz @docsok99 @RameshDaggubati @WvuCvFellows @cardiooncCMB

[Sudarshan Balla @sudarshanballa]

Publication by WVU - COVID‐19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity‐Matched Cohort Study | Journal of the American Heart Association https://t.co/p7ItFHo7ff